Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Needham Upgrades Doximity to Buy, Announces $38 Price Target

Author: Benzinga Newsdesk | August 09, 2024 07:43am
Needham analyst Scott Berg upgrades Doximity (NYSE:DOCS) from Hold to Buy and announces $38 price target.

Posted In: DOCS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist